2 studies found for: FOLFOX plus bevacizumab, assessing tumor blood flow
MRI in Predicting Response in Patients Receiving Combination Chemotherapy and Bevacizumab For Advanced or Metastatic Colorectal Cancer
|2||Active, not recruiting||
DCE-MRI PET Bevacizumab Study in Rectal Cancer
† Study has passed its completion date and status has not been verified in more than two years.